October 30, 2007 by MedHeadlines
Filed under Cancer, Drugs
Med Headlines - The Food and Drug Administration has approved Tasigna (nilotinib), a new drug for the treatment of Chronic Myeloid Leukemia (CML). Tasigna has been developed by Novartis AG. Read more
Loading ...
Did Marrow Transplant Cure AIDS?
That’s the question abuzz in the medical community as doctors around the globe...
Fan In Baby’s Room Reduces Risk of SIDS
One of the most heartbreaking and frustrating diagnoses discussed today is that of...
Top Economist Says McCain’s Health Plan Better for More Americans
In a Wall Street Journal (WSJ) opinion piece, one of the nation’s top economists...
More Editor's Picks
